← SynDRA
KETANSERIN
SynDRA canonical compound SYN0000258 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Primary target(s) | HTR2C |
| Mechanism of action | Serotonin receptor antagonist |
| Indication | hypertension |
| Disease area | cardiology |
All known targets
- HTR2C
- HTR2A
- DRD5
- HTR1A
- ADRA1B
- ADRA1D
- SLC18A2
- SLC18A1
- HTR5A
- HTR2B
- DRD1
- ADRA1A
Mechanisms of action (all sources)
- Serotonin receptor antagonist
- HTR1A ANTAGONIST
- HTR1B ANTAGONIST
- HTR1D ANTAGONIST
- HTR2A ANTAGONIST
- HTR2B ANTAGONIST
- HTR2C ANTAGONIST
- HTR5A ANTAGONIST
- HTR7 ANTAGONIST
- ADRA1A ANTAGONIST
- ADRA1B ANTAGONIST
- ADRA1D ANTAGONIST
Drug classes
- Antihypertensive Agents
- Cardiovascular Agents
- Hematologic Agents
- Neurotransmitter Agents
- Platelet Aggregation Inhibitors
- Serotonin Agents
- Serotonin Antagonists
ATC classes
- C02K · OTHER ANTIHYPERTENSIVES
Cross-references
Synonyms
- R 41 468
- ketensin
- suffrexal
- ketanserin tartrate hydrate
- ketanserin tartrate
- R 41468
- Ketanserine
- Ketanserina
- KETANSERIN TARTRATE
- Perketan
- Serepress
- KJK 945
- NSC-758959
- R-49945
- R-41,468
- R-41468
- Sufrexal
- Ketanserinum
- Ketaserin
- Perketal
- Serefrex
- Taseron
- Ketanserina [INN-Spanish]
- Ketanserine [INN-French]
- Ketanserinum [INN-Latin]
- [3H]-Ketanserin
- Ketanserin (USAN/INN)
- Ketanserin [USAN:BAN:INN]
- (+)-3-[2-[4-(4-Fluorobenzoyl)-1-piperidinyl]ethyl]-2,4(1H,3H)-quinazolinedione
- 3-(2-(4-(4-Fluorobenzoyl)piperidinol)ethyl)-2,4(1H,3H)-quinazolinedione
- 3-(2-(4-(p-Fluorobenzoyl)piperidino)ethyl)-2,4-(1H,3H)-quinazolinedione
- 3-(2-{4-[(4-fluorophenyl)carbonyl]piperidin-1-yl}ethyl)quinazoline-2,4(1H,3H)-dione
- 3-[2-[4-(4-fluorobenzoyl)-1-piperidyl]ethyl]-1H-quinazoline-2,4-dione
- 3-[2-[4-(4-fluorobenzoyl)piperidin-1-yl]ethyl]-1H-quinazoline-2,4-dione
- 3-{2-[4-(4-fluorobenzoyl)piperidin-1-yl]ethyl}quinazoline-2,4(1H,3H)-dione
- R 41,468
- NSC 758959
- CHEBI:6123
Look up KETANSERIN in the interactive SynDRA portal →